InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Israel Biotech Fund I, L.P.. Insider active across 1 company, notably Ayala Pharmaceuticals, Inc.. Aggregated, 3 filings have been published. Breakdown: 2 buys · 0 sell. Activity tracked since 18 October 2023. The latest transaction was disclosed on 7 February 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations